Related Experiment Videos

Oral histoplasmosis in HIV-infected patients. A report of two cases

H Chinn1, D N Chernoff, C A Migliorati

  • 1Division of Oral Medicine, UCSF, USA.

Insights

Histoplasmosis, a fungal infection, can manifest as initial oral lesions in individuals with HIV/AIDS. Despite successful treatment with amphotericin B, recurrences highlight the challenges in managing this opportunistic infection.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Immunocompromised Hosts

Background:

  • Histoplasmosis is a fungal infection caused by Histoplasma capsulatum, typically affecting immunocompromised individuals.
  • Disseminated histoplasmosis is uncommon but documented in patients with Acquired Immunodeficiency Syndrome (AIDS).
  • Oral manifestations of histoplasmosis in HIV-positive patients present with diverse clinical features.

Observation:

  • Two cases of Human Immunodeficiency Virus (HIV)-positive patients presented with oral lesions as the primary sign of histoplasmosis.
  • These oral lesions appeared in various locations and exhibited different clinical presentations.
  • Both patients initially responded positively to intravenous amphotericin B treatment.

Findings:

  • Recurrence of histoplasmosis was observed in both patients.
  • Recurrences occurred even while patients were undergoing systemic antifungal maintenance therapy.
  • This suggests potential challenges in achieving sustained remission for disseminated histoplasmosis in this population.

Implications:

  • Oral lesions can be an early indicator of disseminated histoplasmosis in HIV-positive individuals.
  • Aggressive antifungal therapy is crucial, but long-term management strategies may need further investigation.
  • Understanding recurrence patterns is vital for optimizing treatment protocols for opportunistic fungal infections in immunocompromised patients.

Related Concept Videos